Durantel, David

Publishing since 2000 (Junior)

Has published 28 publications in 11 years

Number of publications published per year by Durantel, David. (Source : PubMed)

Distribution of publications types for Durantel, David. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lucifora J, Vincent IE, Berthillon P, Dupinay T, Michelet M, Protzer U, Zoulim F, Durantel D, Trepo C, Chemin I. Hepatitis B virus replication in primary macaque hepatocytes: Crossing the species barrier toward a new small primate model.  Hepatology  2010  
•  Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F. Control of hepatitis B virus replication by innate response of HepaRG cells.  Hepatology  2010;51;1  
•  Pawlotsky JM, Cocquerel L, Durantel D, Lavillette D, Lerat H, Pécheur EI, Polyak SJ, Tautz N, Thimme R. HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses.  Gastroenterology  2010;138;1  
•  Macovei A, Radulescu C, Lazar C, Petrescu S, Durantel D, Dwek RA, Zitzmann N, Nichita NB. Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells.  J. Virol.  2010;84;1  
•  Durantel D, Zoulim F. Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus.  Hepatology  2009;50;6  
•  Durantel D. Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.  Curr Opin Investig Drugs  2009;10;8  
•  Delang L, Paeshuyse J, Vliegen I, Leyssen P, Obeid S, Durantel D, Zoulim F, Op de Beeck A, Neyts J. Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.  Hepatology  2009;50;1  
•  Dreux M, Dao Thi VL, Fresquet J, Guérin M, Julia Z, Verney G, Durantel D, Zoulim F, Lavillette D, Cosset FL, Bartosch B. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.  PLoS Pathog.  2009;5;2  
•  Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.  Antivir. Ther. (Lond.)  2009;14;1  
•  Zoulim F, Durantel D, Deny P. Management and prevention of drug resistance in chronic hepatitis B.  Liver Int.  2009;29 Suppl 1  

[ See timeline ] [ See all publications ]